The launch of trophon3 and trophon2 Plus set a new benchmark in automated HLD for ultrasound transducers, upholding the trophon technology's market leadership position. These launches reflect our commitment to innovation, customer support and ongoing expansion in this important area of infection prevention.

Chemotherapy-induced alopecia (CIA) remains one of the most distressing side effects of cancer treatment. While scalp cooling is currently the only regulatory-approved method to reduce CIA, its effectiveness varies, particularly across different chemotherapy regimens and patient profiles. That’s why advancing our scientific understanding of how cooling works (and how we can enhance its impact) is vital.

Why use ultrasound for IV access? Clinical guidelines supporting ultrasound-guided IV placement. Clinical use and special populations. Let’s talk about implementation and the next steps.